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ABSTRACT
Iron (Fe2+, Fe3+) homeostasis is a tightly regulated process, involving
precise control of iron influx and egress from cells. Although the
mechanisms of its import into cells by iron carrier molecules are well
characterized, iron export remains poorly understood. The current
paradigm envisages unique functions associated with specialized
macromolecules for its cellular import (transferrin receptors) or
export (ferroportin, also known as SLC40A1). Previous studies
have revealed that iron-depleted cells recruit glyceraldehyde-3-
phosphate dehydrogenase (GAPDH), a multitasking, ‘moonlighting’
protein, to their surface for internalization of the iron carrier
holotransferrin. Here, we report that under the converse condition
of intracellular iron excess, cells switch the isoform of GAPDH on
their surface to one that now recruits iron-free apotransferrin in close
association with ferroportin to facilitate the efflux of iron. Increased
expression of surface GAPDH correlated with increased
apotransferrin binding and enhanced iron export from cells, a
capability lost in GAPDH-knockdown cells. These findings were
confirmed in vivo utilizing a rodent model of iron overload. Besides
identifying for the first time an apotransferrin receptor, our work
uncovers the two-way switching of multifunctional molecules to
manage cellular micronutrient requirements.
KEY WORDS: Apotransferrin, Ferroportin, GAPDH, Iron export,
Higher order multifunctional protein, Receptor
INTRODUCTION
Although iron (Fe2+, Fe3+) is an essential micronutrient for all life it
can be a double-edged sword. It constitutes an essential component
of various proteins that are crucial for oxygen transport and
electron transfer. At the same time, excess iron catalyses the
formation of highly reactive free radicals (through Fenton’s
reaction), which damage biomolecules through peroxidation
(Dunn et al., 2007; Ganz, 2007; Hentze et al., 2004; Knutson and
Wessling-Resnick, 2003). The accumulation of iron in cells and
tissues causes medical complications, including cirrhosis, liver
cancer, pancreatic failure, cardiomyopathy and arthritis (Burke
et al., 2001; Kong et al., 2008). Iron overload also affects the
central nervous system and has been implicated in the pathogenesis
of Parkinson’s and Alzheimer’s diseases (Fleming and Ponka,
2012; Kong et al., 2008). It is therefore imperative for organisms to
constantly maintain control of iron metabolism at all the different
steps involving iron turnover. This involves tight regulation of
the absorption (enterocytes), usage (erythroid cells), recycling
(reticuloendothelial cells) and storage (macrophages and
hepatocytes) of iron (Fleming and Ponka, 2012).
Practically all of extracellular iron in blood is chelated to
transferrin, an abundant serum iron transport protein. Under
physiological conditions, ,30% of the total transferrin is
saturated with iron, leaving no excess free iron available to
cause toxicity (Sheftel et al., 2012). Although the cellular iron
uptake pathways through transferrin receptor proteins 1 and 2
[TfR1 (also known as CD71) and TfR2] are well characterized,
knowledge regarding iron export is still limited (Ganz, 2007).
Ferroportin [also known as iron-regulated transporter1 (IREG1),
metal transporter protein 1 (MTP1) or SLC40A1] is the only
known iron exporter in mammalian cells (Abboud and Haile,
2000; Donovan et al., 2000; McKie et al., 2000). It is expressed in
duodenal enterocytes, tissue macrophages and hepatocytes, where
it participates in cellular release of iron (Abboud and Haile, 2000;
Canonne-Hergaux et al., 2006; Donovan et al., 2000; McKie
et al., 2000; Ramey et al., 2010). Iron loading of cells enhances
the localization of ferroportin to the plasma membrane of
macrophages (Delaby et al., 2005); however, the exact
mechanism by which ferroportin transports iron and how the
exported iron is sequestered remains unclear (Ganz, 2007; Le Gac
et al., 2013; Wessling-Resnick, 2006).
Previously it has been shown that the multifunctional
glycolytic enzyme glyceradehyde-3-phosphate dehydrogenase
functions as a receptor for holotransferrin (i.e. iron-saturated
transferrin) and lactoferrin (also known as lactotransferrin) on the
surface of a diverse range of cell types, including macrophages,
and upon iron starvation many cells prefer to use surface-
localized GAPDH for holotransferrin uptake rather than TfR1
(Kumar et al., 2012; Modun et al., 1998; Modun et al., 2000; Raje
et al., 2007; Rawat et al., 2012). Recently, we have also
demonstrated that cells enhance their secretion of GAPDH into
the extracellular milieu (sGAPDH) when they are depleted of
iron. This sGAPDH functions as an autocrine and/or paracrine
receptor that traffics holotransferrin into various tissues and cell
types (Sheokand et al., 2013). In the current study, we report an
additional dimension to the multifunctionality of GAPDH,
whereby the same protein demonstrates contrasting behavior
under the opposing condition of cellular iron status (i.e. excess
intracellular iron) to maintain iron homeostasis. Using cell types
that play a key role in maintaining iron homeostasis (cells of the
reticuloendothelial system, hepatocytes and enterocytes) we
provide evidence that, when exposed to iron overload, cells
again enhance their recruitment of GAPDH to the membrane
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surface. However, this GAPDH is an alternate isoform, which
differs from that recruited upon iron starvation. It does not bind to
holotransferrin; instead, it interacts with apotransferrin with high
affinity and facilitates the export of iron from cells. This
capability is lost in cells where GAPDH knockdown is
performed. We further demonstrate that in iron loaded cells
GAPDH interacts with ferroportin on the cell surface, which
might facilitate the loading of iron exported by ferroportin onto
apotransferrin. The results from our cell culture experiments were
validated in vivo utilizing rodent models of iron overload.
RESULTS
Modulation of cell-surface GAPDH upon iron overload
Previously, we have demonstrated that iron starvation enhances
surface GAPDH expression and many cells prefer this portal for
holotransferrin acquisition instead of the well-studied TfR1
(Kumar et al., 2012). We were interested to investigate the
response of this receptor system under conditions of iron excess
in cells. To this end, we first confirmed cellular iron loading by
two independent methods. Cells that play a key role in iron
homeostasis were monitored for increased intracellular iron levels
upon incubation with iron. A gradual increase in intracellular iron
peaking at 12 hours was observed (supplementary material Fig.
S1A). In addition, iron loading of macrophages was also achieved
by erythrophagocytosis (EPG), a phenomenon that occurs
naturally in organisms during clearance and recycling of effete
erythrocytes (supplementary material Fig. S1B, and inset).
Surface TfR1 expression decreased in iron-loaded cells
(supplementary material Fig. S1C,D), which is consistent with
earlier reports of cells trying to limit further iron import (Auriac
et al., 2010; Casey et al., 1988). At the same time, we detected
an increased surface expression of GAPDH on primary
macrophages, hepatocytes and macrophage cell lines, along
with a decrease in the case of primary enterocytes (Table 1). In
vivo experiments gave similar results. Peritoneal macrophages
harvested from mice that had been injected intraperitoneally
with iron dextran or opsonized red blood cells (RBCs) also
demonstrated enhanced surface GAPDH (Table 1). The increase
in surface GAPDH was time and dose dependent with respect to
iron loading and did not involve any change in intracellular
GAPDH levels (Fig. 1A,B). Previously, we have reported an
increase in the amount of GAPDH on the surface of iron-starved
cells (Kumar et al., 2012; Raje et al., 2007). When compared with
those observations, we noticed that the extent of increase in
GAPDH expression on the membrane was significantly higher
upon iron loading of cells as compared with that observed during
iron depletion (Fig. 1C).
GAPDH expressed on the cell membranes of iron-overloaded
cells is of a different form than that observed upon
iron starvation
To determine whether there was any difference in the nature of
GAPDH expressed on cell surface upon iron overload as
compared with that observed during iron depletion, we looked
at the membrane partitioning of GAPDH in the two cases. Our
previous work has demonstrated an increase in the FCDR ratio
[the ratio of flow cytometric signal of the target molecule in the
detergent-resistant membrane fraction (DRM) versus total signal
(Gombos et al., 2004)] of GAPDH upon iron starvation of cells,
indicating that the GAPDH present on the cell surface upon
cellular iron depletion is preferentially localized to the detergent-
resistant fraction of the membrane (Kumar et al., 2012).
Interestingly, in the case of iron-overloaded cells, although the
amount of surface GAPDH increased to a greater extent, no
significant change in the FCDR ratio, as compared with that of
control cells, could be observed (Fig. 1D,E), suggesting that the
increased GAPDH is equally distributed between both membrane
fractions. Analysis of membrane protein fractions by two-
dimensional (2D) gel electrophoresis and western blotting
revealed an alkaline shift in the predominant GAPDH isoforms
of iron-loaded cells as compared with those of iron-depleted cells
(Fig. 1F). Liquid chromatography-tandem mass spectrometry
(LC-MS/MS) analysis of membrane-associated GAPDH from
iron-depleted cells revealed a higher abundance of numerous
post-translational modifications (PTMs), including oxidation,
dimethylation, acetylation, nitrosylation and phosphorylation, as
compared with GAPDH from the membranes of iron-loaded cells
(Fig. 2A–C).
The increase in surface GAPDH upon iron overload also did
not result in any increase in the cellular capacity to bind to
Table 1. Fold change in surface expression of GAPDH and apotransferrin binding upon iron overload as compared with control
cells at 24 hours
Experimental iron overload Cell type Surface GAPDH Apotransferrin binding
Ex vivo FeCl3 Rat hepatocytes 2.70 1.84
Rat peritoneal macrophages 4.00 2.17
Rat spleen macrophages 1.83 1.45
Rat enterocytes 0.75 0.74
J774 3.38 2.77
RAW 1.78 1.59
THP1 2.41 1.94
GAPDH-knockdown THP1 ND# ND#
Erythrocyte phagocytosis Rat spleen macrophages 1.46 1.56
J774 2.40 2.00
THP1 1.77 1.52
GAPDH-knockdown THP1 ND# ND#
In vivo Iron dextran Rat peritoneal macrophages 1.48 1.62
Erythrocyte phagocytosis Rat peritoneal macrophages 2.06 5.50
Different cell types were subjected to iron overload either ex vivo (by FeCl3 or RBC phagocytosis for 24 hours) or by intraperitoneal injection of iron dextran or
opsonized erythrocytes into male Sprague-Dawley rats. Peritoneal macrophages were isolated at 24 hours. Controls were set up in parallel (see Materials and
Methods for details). The surface expression of GAPDH and apotransferrin binding was evaluated by flow cytometry; P,0.0001 in all cases except those
marked with a hash (#). ND, not detectable; n5104 cells in each case; all experiments repeated at least three times.
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holotransferrin as reported previously for iron-depleted cells
(Kumar et al., 2012); in fact, there is a significant decrease
(Fig. 3A). These results collectively demonstrate that GAPDH
recruited to the cell surface during iron overload is a different
isoform than that presented upon iron starvation.
Modulation of apotransferrin binding upon iron overload
As excess iron is deleterious, iron-loaded cells would seek to
divest themselves of this excess of metal. Apotransferrin,
abundantly present in serum, is among the best known
biological chelators of iron, and we checked for its recruitment
Fig. 1. Modulation and
characterization of surface GAPDH
upon iron loading of cells. (A) J774
cells were cultured in 100 mM-FeCl3-
supplemented medium for increasing
time periods and checked for changes
in surface-associated GAPDH as well
as intracellular expression of GAPDH by
flow cytometric analysis. Extracellular
GAPDH was also monitored for
ectoenzyme activity. Surface and
intracellular GAPDH data are presented
as a percentage of the mean
fluorescence intensity of control
samples; P,0.005; *P.0.05; n5104
cells. For ectoenzyme activity, data are
presented as a percentage of the OD at
340 nm of the control sample;
P,0.0005; n54 independent
experiments. (B) J774 cells were treated
with increasing concentrations of iron up
to 100 mM FeCl3, and the surface
expression of GAPDH was evaluated.
Data are presented as a percentage of
the mean fluorescence intensity of
control samples; P,0.0001; n5104
cells. (C) The increase in the amount of
cell surface GAPDH is significantly
larger upon iron loading of cells
compared with that observed following
iron depletion. J774 cells were treated
with either 100 mM FeCl3 or 100 mM
DFO for 24 hours before flow-
cytometry-based analysis of surface
GAPDH; P,0.0001; n5104 cells.
(D,E) GAPDH is present in both DRM
and non-DRM membrane fractions in
control as well as iron-loaded J774 cells;
P,0.0001 (statistical analysis was
performed using mean fluorescence
intensities); n5104 cells. (F) Western
blot of 2D-gel-electrophoresis-
separated GAPDH isoforms from
membrane fractions of iron-loaded
(100 mM FeCl3) and iron-depleted
(100 mM DFO) J774 cells. pI, isoelectric
point. Also see supplementary material
Fig. S1.
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to iron-loaded cells. Macrophages and hepatocytes demonstrated
an increased binding of apotransferrin, which correlated with the
increase in surface GAPDH expression (Fig. 1A–D; Fig. 3B;
Table 1). In the case of primary enterocytes, surface GAPDH
decreased along with a corresponding decrease in apotransferrin
binding (Table 1). GAPDH-knockdown THP1 cells, which fail to
enhance surface GAPDH upon iron overload, also lacked
apotransferrin binding (Table 1). The increase in apotransferrin
binding by cells also matched the time-dependent increase in the
amount of surface GAPDH upon iron loading (Fig. 3C; Fig. 1A).
Apotransferrin binding to cells
The equilibrium dissociation constant (KD) of apotransferrin
binding to the surface of excess-iron-treated J774 cells was
calculated to be 1.11 nM (Fig. 3D), suggesting the presence of a
high-affinity receptor. This is similar to the value of 1 nM
reported for TfR1, and there could be some concern that the
affinity reported in this case is due to transferrin binding to TfR1
either in the apo form or after conversion into holotransferrin.
However, TfR1 does not bind to apotransferrin at physiological
pH (Andrews, 2000), and apotransferrin was prevented from
conversion to the holo form by the inclusion of desferrioxamine
(DFO) in the incubation buffer (Kawabata et al., 2000). Flow
cytometric analysis demonstrated that apotransferrin binding to
cells is inhibited in the presence of excess of unlabeled ligand
(Fig. 3E), indicating that it is a specific process. In addition, the
binding was decreased when cells were pretreated with the
proteolytic enzyme pronase (Fig. 3F), confirming that the
receptor involves a protein molecule (Kumar et al., 2012).
GAPDH and apotransferrin interact in vitro
As surface GAPDH appeared to be a receptor for apotransferrin
binding on iron-loaded cells, we decided to first check whether
GAPDH and apotransferrin interact in vitro. To evaluate this,
plate-based solid-phase interaction and surface plasmon
resonance (SPR) assays were performed. GAPDH coated in
enzyme-linked immunosorbent assay (ELISA) wells specifically
captured apotransferrin (supplementary material Fig. S2A). A
Biacore assay revealed a KD of 5.3 nM for the GAPDH–
apotransferrin interaction (supplementary material Fig. S2B).
GAPDH and apotransferrin colocalize and interact on the
cell surface
To ascertain whether this strong in vitro interaction of GAPDH
and apotransferrin occurs in vivo, we investigated the association
and interaction of GAPDH with apotransferrin on the surface of
iron-treated J774 cells. Utilizing confocal microscopy, GAPDH
was observed to colocalize with apotransferrin on the surface of
Fig. 2. LC-MS/MS analysis of membrane-associated
GAPDH from iron-depleted and iron-loaded cells.
J774 cells were cultured in medium supplemented with
100 mM FeCl3 or 100 mM DFO for 24 hours, and
membrane fractions were purified. Membrane proteins
from both samples were extracted and subjected to 12%
SDS-PAGE. Bands corresponding to GAPDH were
excised and trypsin digested. Peptide analysis by Mascot
following LC-MS/MS confirmed proteins to be GAPDH.
The MOWSE score was .700, with sequence coverage
of .80% in both cases. (A) PTMs observed in GAPDH
recruited to the cell membrane upon iron depletion in
J774 cells. (B) PTMs observed in GAPDH recruited to the
cell membrane upon iron overload in J774 cells.
(C) Comparative analysis of various PTMs and the
corresponding modified residues in GAPDH recruited to
the cell membrane under both conditions.
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cells (Fig. 4A; supplementary material Fig. S2C,D). An acceptor-
photobleaching-based Foster resonance energy transfer (FRET)
assay also demonstrated an interaction between surface GAPDH
and apotransferrin (Fig. 4B,C; supplementary material Fig. S2E).
Finally, co-immunoprecipitation of biotinylated apotransferrin
with GAPDH from the membranes of iron-loaded cells confirmed
the interaction between the two proteins (Fig. 4D).
Correlated modulation of surface GAPDH and apotransferrin
binding in iron-loaded rats
We utilized an in vivo rat model to determine whether iron
loading indeed increases cell-surface GAPDH and apotransferrin
binding. Liver and serum iron estimation confirmed the iron
overload in a rat model (supplementary material Fig. S3A,B).
Hepatocytes, peritoneal macrophages and enterocytes were
examined for surface expression of GAPDH and apotransferrin
binding as compared with that of cells isolated from control
animals. Whereas hepatocytes and peritoneal macrophages of
iron-loaded rats demonstrated an increase in surface GAPDH
expression along with a corresponding increase in apotransferrin
binding, enterocytes demonstrated a decrease in both surface
expression of GAPDH and apotransferrin binding (Fig. 5A;
supplementary material Fig. S3C). The change in cell-surface
expression of GAPDH upon iron loading correlated well with the
change in apotransferrin binding by all three cell types studied
(Fig. 5B).
Apotransferrin recruited by GAPDH facilitates iron export
To understand the physiological significance of increased
apotransferrin capture by iron-loaded cells, we explored its role
in the facilitation of iron export from cells. Having established
that incubation with iron-supplemented medium causes maximum
intracellular iron accumulation within 12 hours (supplementary
material Fig. S1A), we chose this as a starting point from which
to evaluate iron exit. When apotransferrin was included in the
incubation medium, iron-loaded J774 cells demonstrated a
significant enhancement of iron export into the extracellular
medium within 1 hour, as assayed by the chromogenic iron assay
(supplementary material Fig. S4A). Exit of iron was also
quantified using cells labeled with 55Fe. We observed an
increase in iron export from various iron-loaded (by FeCl3
incubation or EPG) cells when incubated with apotransferrin
(Fig. 6A,B). J774 and THP1 cells that had not been subjected to
any iron loading (untreated control cells) also demonstrated a
Fig. 3. The binding of apotransferrin to iron-
loaded cells is selectively enhanced. (A) There
is a significant decrease in cell-surface
holotransferrin–Alexa-Fluor-647 binding by iron-
loaded J774 cells; P,0.05; n5104 cells.
(B) Apotransferrin–Alexa-Fluor-647 binding is
increased on the surface of iron-loaded J774 cells;
P,0.0001; n5104 cells. (C) The magnitude of the
increase in apotransferrin (Apo Tf) binding
increases with the length of exposure to iron. J774
cells were treated with 100 mM FeCl3 for increasing
lengths of time and the binding of apotransferrin–
Alexa-Fluor-647 was measured. The data are
presented as a percentage of mean fluorescence
intensity of control samples; P,0.005; n5104 cells.
(D) Concentration-dependent binding of
apotransferrin on the surface of iron-loaded J774
cells. The results are expressed as the
concentration of biotinylated apotransferrin versus
OD at 450 nm (6s.d.). (E,F) The binding of
apotransferrin to the surface of iron-treated J774
cells is specific (E) and pronase sensitive (F);
P,0.0001; n5104 cells. All experiments were
repeated three times.
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small baseline change in iron export when apotransferrin was
added into the incubation medium (supplementary material Fig.
S4B). Interestingly, incubation with apotransferrin caused a sharp
increase in iron export from untreated enterocytes, whereas in
iron-loaded enterocytes the effect of apotransferrin was minimal
(supplementary material Fig. S4B; Fig. 6A). The addition of
apotransferrin failed to enhance iron export from untreated or
iron-loaded GAPDH-knockdown THP1 cells (Fig. 6A,B;
supplementary material Fig. S4B). In addition, this effect of
apotransferrin in enhancing iron exit was dose dependent and
could not be brought about by holotransferrin (Fig. 6C). We
further confirmed that the iron exported out of cells is sequestered
into apotransferrin (Fig. 6D) by precipitating the added
apotransferrin and checking for the presence of protein-bound
radioactive iron.
Surface GAPDH colocalizes and interacts with ferroportin
Ferroportin, the only known iron exporter in mammals, is known
to localize to the cell membrane upon iron loading (Delaby
et al., 2005). Having observed that, in iron-loaded cells,
surface GAPDH recruits apotransferrin to facilitate cellular
iron export (Figs 4–6), we decided to evaluate the possibility
of any GAPDH–ferroportin interaction on the surface of these
cells. Confocal microscopy demonstrated the simultaneous
colocalization of all three proteins on cells (Fig. 7A). Acceptor-
photobleaching-based FRET analysis demonstrated the interaction
between GAPDH and ferroportin (Fig. 7B–D). Finally, co-
immunoprecipitation of surface GAPDH and ferroportin
confirmed the interaction between the two proteins (Fig. 7E).
DISCUSSION
Iron metabolism has long been an area of active research (Ganz,
2013) and, although extensive studies have been conducted to
characterize the mechanistic basis of iron import by cells, the
field of cellular iron export is still poorly explored. In our earlier
studies, when cells were depleted of iron, we observed an
increase in the recruitment of GAPDH to the cell surface, which
enhanced holotransferrin trafficking, demonstrating the role of
GAPDH in maintaining essential levels of cellular iron (Kumar
et al., 2012; Raje et al., 2007). To fully comprehend its role in
iron homeostasis, we investigated how this molecule responds
when cells are loaded with iron (under such situations TfR1
expression on cells is known to be downregulated). Interestingly,
we once again observed an increase (to an even greater extent
than was observed upon iron depletion) in the surface expression
of GAPDH in macrophages and hepatocytes. Unlike our earlier
observations in iron-starved cells (Kumar et al., 2012), and also in
agreement with an earlier report showing that iron loading did not
Fig. 4. Cell-surface GAPDH interacts with apotransferrin on the cell surface. (A) Colocalization of GAPDH and apotransferrin–FITC (Apo Tf) on the surface
of excess-iron-treated J774 cells, as determined using confocal microscopy. Pearson’s correlation coefficient is 0.94; also see supplementary material Fig.
S2C,D. GAPDH was detected with the mouse monoclonal anti-GAPDH antibody and anti-mouse-IgG–Alexa-Fluor-568. Scale bars: 20mm. (B) GAPDH on the
surface of excess-iron-treated J774 cells interacts with apotransferrin as seen by FRETsignal, which is represented by an increase (arrowheads) in donor signal
(anti-GAPDH–TRITC) upon bleaching of the acceptor (apotransferrin–Alexa-Fluor-647). Scale bars: 5 mm. (C) FRET efficiency [signal intensity of (Donorpost
Bleach2Donorpre Bleach)/Donorpost Bleach6100] was compared to that of control, where instead of apotransferrin–Alexa-Fluor-647 the unrelated goat-IgG–Alexa-
Fluor-647 was used; P,0.0001; n525 cells. (D) Excess-iron-treated J774 cells were incubated with biotinylated apotransferrin at 4˚C, and the membrane
fraction was prepared and subjected to co-immunoprecipitation (Co-IP) using streptavidin–Magnabeads. The interaction between GAPDH and apotransferrin
was confirmed by western blotting using monoclonal anti-GAPDH antibody. A negative (-ve) control was run in parallel, wherein the incubation of cells with
biotinylated apotransferrin was omitted. Std., standard (rabbit muscle GAPDH). See also supplementary material Fig. S2.
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alter GAPDH expression in rat liver (Quail and Yeoh, 1995), no
change in intracellular GAPDH levels upon iron loading was
observed. These observations suggest that the increase in the
amount of membrane-associated GAPDH could be due to
redeployment of the existing intracellular protein to the
membrane. Because membrane-associated GAPDH accounts for
a tiny fraction of the vast pool of intracellular GAPDH (Seidler,
2013), no discernible alteration in cytosolic levels would be
perceptible. Our results also demonstrate that the GAPDH
recruited to the cell membrane upon iron overload is of a
different isoform than that deployed upon iron depletion. The
existence of discrete GAPDH isoforms catalyzing independent
functional activities is well known (Glaser and Gross, 1995;
Seidler, 2013), and a switching of GAPDH in the membrane of
bone-marrow-derived macrophages upon iron loading to a more
alkaline isoform has been reported recently (Polati et al., 2012).
Our LC-MS/MS results demonstrate that GAPDH recruited upon
iron loading lacks phosphorylation and acetylation and also
has a lower abundance of several PTMs, including oxidation,
dimethylation and nitrosylation in comparison to GAPDH
recruited upon iron depletion. These modifications are well
known for their ability to shift the isoelectric point of proteins as
observed by us in this study, as well as by numerous other
workers previously (Choudhary et al., 2000; Grillon et al., 2012;
Kuyumcu-Martinez et al., 2007; Madian et al., 2012; Park et al.,
1988; Zhang et al., 2011). The presence of numerous PTMs in
GAPDH has been well established in earlier reports (Seidler,
2013; Seo et al., 2008).
Unlike the GAPDH recruited upon iron depletion (Kumar
et al., 2012), GAPDH expressed on the membrane during iron
overload does not bind to holotransferrin. This is expected as
under these conditions cells are already coping with an excess of
the metal and would seek to restrict further iron import through
holotransferrin. By contrast, these cells have an urgent need to
externalize their excess iron. As a high level of extracellular free
iron is deleterious, the exported iron needs to be expeditiously
chelated from the vicinity of the cell (Hentze et al., 2004). One of
the most abundant and high-affinity chelators of iron in serum
capable of this task is apotransferrin (Sheftel et al., 2012), and the
existence of an independent apotransferrin receptor for such a
Fig. 5. Modulation of cell-surface GAPDH and
apotransferrin binding in cells isolated from chronically
iron-loaded Sprague-Dawley rats. (A) Primary hepatocytes
and peritoneal macrophages isolated from iron-loaded rats
demonstrate increases in both surface GAPDH expression
and apotransferrin (Apo Tf) binding as compared with that of
cells isolated from control rats; P,0.05 (hepatocytes),
P,0.002 (peritoneal macrophages); n53 test animals.
Enterocytes isolated from iron-loaded rats showed a
decrease in both surface GAPDH expression and
apotransferrin binding in comparison to cells isolated from
control rats; P,0.001; n53. From each test animal, 104 cells
were analyzed by flow cytometry for each parameter
separately, and the results are presented as the mean
fluorescence intensity (MFI)6 s.d. The data are
representative of five independent experiments (see
supplementary material Fig. S3 for results of all five groups).
(B) Correlation between the change in expression of surface
GAPDH and apotransferrin binding to cells from all iron-
loaded animals. See also supplementary material Fig. S3.
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purpose has been suggested previously (Umbreit, 2005). We
examined apotransferrin binding to the surface of iron-loaded
cells and observed an increase upon iron loading. This correlated
with the increased amount of surface GAPDH in various cells
analyzed. Cells in which GAPDH had been knocked down, which
thus did not express GAPDH on their surface, completely failed
to bind to apotransferrin either under normal conditions or upon
iron overload (Table 1). The binding of apotransferrin was
modulated in a time-dependent manner similar to the increase in
the amount of surface GAPDH. In addition, it was specific,
saturable and pronase sensitive, demonstrating the involvement of
a protein receptor with an affinity of ,1 nM. Earlier
investigations have suggested the existence of such specific,
saturable and pronase-sensitive binding of apotransferrin to rat
peritoneal macrophages, involving very-high-affinity receptors
and occurring independently of holotransferrin binding (Nishisato
and Aisen, 1982). However, to date, no specific molecule has
been identified as an apotransferrin receptor. Our data suggests
that this high-affinity receptor for apotransferrin on the surface of
macrophages is an isoform of GAPDH.
Biacore-based analysis revealed the affinity of the GAPDH–
apotransferrin interaction to be of the same order as that of the
transferrin–TfR1 interaction and also to correlate with the binding
affinity of apotransferrin for iron-loaded cells. Confocal
microscopy based colocalization, co-immunoprecipitation and
FRET-based assays further confirmed the interaction of GAPDH
and apotransferrin on cells. A study utilizing K562 cells
suggested the existence of common apo and holotransferrin-
binding sites (Xiu-Lian et al., 2004). However, K562 cells do not
express GAPDH on their surface at all (Kumar et al., 2012), and
those results might be due to the existence of some alternative
binding sites.
Our studies provide evidence that the interaction of
apotransferrin with iron-loaded cells facilitates the exit of iron
and that this ability is lost upon knockdown of GAPDH. These
results demonstrate that surface GAPDH and apotransferrin are
crucial for iron egress. The role of apotransferrin in iron export has
been demonstrated previously with mixed results. It enhanced iron
release from rat Kupffer cells, bone marrow macrophages (Kondo
et al., 1988; Rama et al., 1988) and hypoxic macrophages in the
presence of ceruloplasmin (Sarkar et al., 2003). In vivo studies have
demonstrated that iron infused to decrease plasma iron-binding
capacity (by decreasing levels of serum apotransferrin) reduces
post-EPG cellular iron release (Bergamaschi et al., 1986; Lipschitz
et al., 1971; Siegenberg et al., 1990), and rat bone marrow
macrophages exhibit a suppressed iron release when incubated
with saturated transferrin (Rama et al., 1988). However, other
groups have reported that apotransferrin has no effect on iron
release after infusion of RBCs (Lipschitz et al., 1971) or after EPG
in isolated rat peritoneal macrophages (Saito et al., 1986).
As ferroportin is a well-established iron exporter in mammals,
we investigated whether surface GAPDH interacts with
ferroportin and confirmed this to be the case in iron-loaded
macrophages. We hypothesize that GAPDH recruits
Fig. 6. GAPDH facilitates iron export by
apotransferrin in iron-loaded cells. (A,B) Cell lines
and rat primary cells were iron loaded using either
treatment with 100 mM FeCl3 (A) or EPG (B) in
medium spiked with 55Fe for 12 hours. Subsequent
incubation of cells with apotransferrin (Apo Tf)
resulted in enhanced iron export into the incubation
medium as compared with that observed in cells
where apotransferrin was omitted; P,0.0005,
*P,0.001, #P.0.05; n54 experimental replicates.
Data are presented as a percentage of counts per
minute (CPM) in incubation medium of cells
incubated without apotransferrin, shown as the
mean6s.d.; each experiment was repeated multiple
times. (C) The effect of apotransferrin in enhancing
iron exit is dose dependent. J774 cells treated with
100 mM FeCl3 (spiked with 55FeCl3) were incubated
with increasing concentrations of apotransferrin or
4 mg/ml holotransferrin (Holo Tf) (the maximum
concentration of apotransferrin tested) and iron exit
into the incubation medium was quantified;
P,0.0001, #P.0.05; n54 experimental replicates.
Data are presented as a percentage of CPM in the
incubation medium of cells incubated without
apotransferrin, shown as the mean6s.d. (D) Iron
released by cells is loaded onto apotransferrin. J774
cells loaded with iron as above were incubated with
0.5 mg/ml of biotinylated apotransferrin, and after
immunoprecipitation of apotransferrin from cell
supernatants with streptavidin–Magnabeads the
captured radioactive iron was visualized on
nitrocellulose membrane by phosphoimaging. A
negative (-ve) control where incubation with
biotinylated apotransferrin was omitted was run in
parallel. See also supplementary material Fig. S4.
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apotransferrin onto the cell surface, thereby increasing its local
concentration in close proximity to ferroportin, so that iron
exported through ferroportin is rapidly chelated. This is crucial,
as localized high concentrations of free iron around the cell
membrane can cause lipid peroxidation and compromise
membrane integrity. Studies in Xenopus oocytes (which express
ferroportin) have demonstrated the requirement of apotransferrin
for increased iron efflux (Donovan et al., 2000). The increase in
cell surface GAPDH upon iron overload, observed by us, also
matches with the previously reported alterations in ferroportin
expression in different cell types. Upon iron loading, ferroportin
expression is decreased on the basolateral surface of enterocytes
so as to decrease iron entry into the systemic circulation (Thomas
and Oates, 2004). By contrast, ferroportin expression is increased
on the surface of macrophages and hepatocytes to facilitate iron
export out of these cells for maintaining homeostasis (Delaby et al.,
2005; Ramey et al., 2010). In accordance with these reports, we
have observed a decreased surface GAPDH expression, decrease in
apotransferrin binding and a marginal effect on iron export in iron-
loaded enterocytes upon incubation with apotransferrin, whereas
control untreated enterocytes displayed a significant increase in
iron export when incubated with apotransferrin. This can be
explained by the fact that enterocytes are involved in dietary iron
absorption and they export iron absorbed from the gut lumen into
systemic circulation, thus making it available to the whole
organism. In presence of excess iron, they would seek to
minimize their iron export into the plasma so as to restrict the
addition of more iron into the circulation. Macrophages and
Fig. 7. GAPDH and ferroportin interact at the surface
of iron-loaded J774 cells. (A) Colocalization of
GAPDH, ferroportin and apotransferrin (Apo Tf) on the
surface of iron-treated J774 cells by confocal
microscopy. Pearson’s correlation coefficient is 0.92 for
the localization of ferroportin with GAPDH and
apotransferrin, and 0.95 for that of GAPDH with
apotransferrin. (B) GAPDH on the surface of iron-loaded
J774 cells interacts with ferroportin as observed by
FRET signal (arrows), represented by an increase in
donor signal (ferroportin) upon bleaching of the acceptor
(GAPDH). Scale bars: 5 mm. (C) GAPDH–ferroportin
FRET control, where instead of specific antibody against
ferroportin, control goat IgG was utilized for donor
staining. The acceptor is same as in Fig. 6B. Scale bars:
10 mm. (D) FRET efficiency (calculated as described in
for Fig. 3C) as compared to that of nonspecific control
(instead of goat anti-ferroportin antibody normal goat
IgG was utilized); P,0.0001; n515 cells. (E) Co-
immunoprecipitation (Co-IP) of ferroportin and GAPDH
from the cell surface of iron-loaded J774 cells. The
membrane fraction was prepared from iron-treated J774
cells (26107 cells) and immunoprecipitated using mouse
monoclonal anti-GAPDH immobilized on anti-mouse-
IgG2Magnabeads. Interaction with ferroportin was
confirmed by western blotting with goat anti-ferroportin
antibody. A negative (-ve) control was run in parallel,
wherein the membrane fraction was co-
immunoprecipitated using isotype control mouse IgG
immobilized on anti-mouse-IgG–Magnabeads, whereas
the membrane fraction of iron-loaded J774 cells served
as positive control for ferroportin. (F) Higher-order
multifunctionality of GAPDH – a model for its role in
cellular iron efflux.
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hepatocytes demonstrated increased surface GAPDH and
apotransferrin binding upon iron overload (as has been reported
for ferroportin) to maintain iron homeostasis. Our in vivo studies
in iron-loaded rats validated our results from cell culture
experiments. We found an increase in surface GAPDH
expression and apotransferrin binding in hepatocytes and
peritoneal macrophages, whereas both decrease in the case of
enterocytes as compared with cells isolated from control rats.
GAPDH is a protein with a diverse range of functions (Sirover,
2011; Sirover, 2012). Previous investigations revealed an
additional role for GAPDH as a receptor for the trafficking of
holotransferrin into iron-starved cells. Here, we demonstrate that,
by changing the isoform recruited to the membrane, GAPDH
additionally functions as a high-affinity receptor for apotransferrin,
thereby maintaining iron homeostasis by enhancing cellular
iron egress. Our current studies uncover an additional order
of multifunctionality for GAPDH (multifunctionality within
multifunctionality), wherein it switches its role under the
diametrically opposite conditions of cellular iron status, providing
a two-way switch based on the modification of PTMs for cellular
iron regulation. In addition, to the best of our knowledge this is also
the first report that clearly identifies a high-affinity apotransferrin
receptor and provides a clear mechanism for its role in managing
cellular iron. A schematic model of this dual role of GAPDH is
outlined in Fig. 7F.
MATERIALS AND METHODS
Cell lines, primary cells and materials
All cell lines (including a stable THP1 cell line in which knockdown of
total cellular GAPDH had been previously established), primary cells
(Sprague Dawley rat peritoneal and spleen macrophages, enterocytes and
hepatocytes) were obtained, purified and maintained essentially as
described previously (Sheokand et al., 2013). THP1 cells were activated
for 24 hours with 12.5 ng/ml of phorbol 12-myristate 13-acetate (PMA).
All cells were maintained in RPMI-1640 medium supplemented with
10% fetal calf serum.
Purified RBCs were labeled by using the CellVueH Claret Far Red
Florescent Cell Linker Midi Kit (Sigma) as per the manufacturer’s instructions.
Rabbit anti-RBC serum was raised and validated using standard methods.
Erythrocytes were opsonized by incubation with antisera (1:50 dilution) at
37 C˚ for 1 hour followed by three washes with PBS. Animal experiments and
the collection of blood from healthy volunteers was performed with due
approval from the relevant institutional ethical committees.
Cell treatments
The iron concentration of cells was increased by culturing cells in medium
containing 100 mM FeCl3 as described previously (Foster et al., 2001).
Excess iron was thus presented as ferrous ascorbate to increase solubility
and facilitate cellular accumulation (Han et al., 1995). Iron in macrophage
cells was also enhanced by erythrophagocytosis (EPG), which was
performed by incubating a monolayer of macrophages with opsonized
RBCs (50:1) for 24 hours in complete medium (Knutson et al., 2005).
Controls were set up in parallel with normal medium. Extracellular RBCs
were lysed with distilled water for 2 minutes, followed by rinsing cells
with neutral buffer (20 mM HEPES, 150 mM NaCl, 5 mM KCl and 1 mM
each of CaCl2 and MgCl2). For in vivo acute iron loading, Sprague Dawley
rats were injected intraperitoneally with 100 mg iron dextran (Sigma) or
16109 opsonized RBCs and, after 24 hours, peritoneal macrophages were
isolated as described previously (Sheokand et al., 2013). For iron depletion
experiments, cells were cultured in complete medium with 100 mM
desferrioxamine (DFO) as described previously (Kumar et al., 2012). No
significant change in cell viability due to any treatment was observed, as
assessed by several independent viability assays described previously
(Kumar et al., 2012; Sheokand et al., 2013). In addition, a Caspase-GloTM
3/7 assay kit (Promega) was also utilized to confirm the absence of any
induction of cell apoptosis.
Protein conjugates
Rabbit muscle GAPDH was obtained from Sigma, and apotransferrin was
procured from Calbiochem. Proteins were conjugated to flurochromes or
biotin by standard procedures using FITC (Sigma), Hilyte Fluor 647
protein labeling kit (Anaspec) and sulfo-NHS-LC biotin (Pierce).
Calcein quenching assay
Erythrophagocytosis was performed with a monolayer of macrophages as
described above for cell treatments with controls set up in parallel with
normal medium. Subsequently, cells were washed three times with
serum-free medium (SFM) and incubated with 500 nM Calcein AM at
37 C˚ for 10 minutes. After extensive washing with SFM, the
fluorescence of intracellular dye was measured by flow cytometry. As
Calcein fluorescence is quenched by iron, a decrease in cellular
fluorescence is indicative of an increased intracellular labile iron pool.
Enzyme activity of cell surface GAPDH and flow cytometry
analysis
Ectoenzyme activity analysis of intact control or FeCl3-treated J774 cells
was performed essentially as described previously (Raje et al., 2007). All
flow cytometry experiments were performed as described previously
(Raje et al., 2007). Briefly, 26105 cells/tube were stained with 1 mg of
anti-GAPDH antibody (Calbiochem) or isotype control (mouse IgG),
followed by sheep anti-mouse-IgG–FITC (Fab)2 (Sigma), or with anti
TfR1–PE or isotype control (BD), with 10 mg of holotransferrin–Alexa-
Fluor-647 or with apotransferrin–Alexa-Fluor-647. For apotransferrin
staining, 100 mM DFO was included in the incubation buffer so as to
prevent conversion of the apo form of transferrin to holotransferrin.
For intracellular GAPDH staining, cells were fixed with 1%
paraformaldehyde and permeablized using 0.1% saponin at 37 C˚ for
15 minutes before staining. Analysis of 104 cells was performed for each
sample using the FACS Calibur or FACS Verse flow cytometer (BD).
Flow cytometric differential detergent-resistant ratio of GAPDH
Control or iron-loaded J774 cells were analyzed for the FCDR ratio of
surface GAPDH exactly as described previously (Kumar et al., 2012).
2D analysis of membrane-associated GAPDH
J774 cells were treated with DFO or excess iron, and membrane fractions
were prepared essentially as described previously (Raje et al., 2007).
Membrane proteins (200 mg from either DFO- or FeCl3-treated J774
cells) were purified by using the Biorad Protein Cleanup KitH as per the
manufacturer’s instructions and were subsequently dissolved in
solubilization buffer (2 M thiourea, 7 M urea, 3% CHAPS, 20 mM
Tris) to a final volume of 125 ml. IPG 7 cm, pH 3–10 linear gradient
strips (BioRad) were loaded with samples by rehydration-loading.
Isoelectric focusing was performed at 0–250 V for 2 hours (linear),
250 V for 1 hour (rapid) and 250 V–3000 V for 4 hours (linear), then
3000 V was maintained until 15,000 V-hours was achieved. The current
was limited to 50 mA per strip, and the temperature was kept at 20 C˚ for
all isoelectric focusing steps. For the second dimension SDS-PAGE, the
IPG strips were incubated in equilibration buffer 1 (6 M urea, 2% SDS,
20% glycerol, 0.375 M Tris-HCl pH 8.8, 2% DTT) for 10 minutes,
followed by incubation in equilibration buffer 2 (6 M urea, 2% SDS, 20%
glycerol, 0.375 M Tris-HCl pH 8.8, 2.5% iodoacetamide) for another
10 minutes and then transferred onto 4–15% gradient acrylamide gels
(Biorad). The gels were run at 25 mA until the Bromophenol Blue front
had reached the bottom of the gel. Resolved proteins were processed for
western blotting and immunodetection of GAPDH as described
previously (Raje et al., 2007).
LC-MS/MS analysis of membrane-associated GAPDH from iron-
depleted and iron-treated cells
J774 cells were treated with DFO or excess iron, and membrane fractions
were prepared as described above. Extracted membrane proteins (200 mg
from either DFO- or FeCl3-treated J774 cells) were subjected to SDS-PAGE
and stained with Coomassie Brilliant Blue. Bands corresponding to GAPDH
were excised and destained with 200 mM of NH4HCO3 in 40% acetonitrile
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(ACN) at 37 C˚ for 30 minutes. Subsequently, gel pieces were dried in a
Speed VacH and incubated at 37 C˚ in digestion buffer containing 20 ng/ml
trypsin (Sigma) and 40 mM NH4HCO3 in 9% ACN for 18 hours. Finally,
supernatant was collected for digested peptides and subjected to LC-MS/MS
analysis. Peptides were analyzed by ultra-high-performance liquid
chromatography (UPLC)/ESI/MS/MS with mass spectrometer (Q-TOF
6550, Agilent). Peptides were separated using a C4 reversed-phase, 3.5-
mm, 2.16150-mm analytical column (X BridgeTM BEH 300, Waters). A
sample volume of 8 ml was injected, and the flow rate was maintained at
400 ml/min. The mobile phase constituted 90% solution A (0.1% formic acid,
90% water, 10% ACN) and 10% of solution B (0.1% formic acid, 90% ACN,
10% water) for 15 minutes, 70% solution A:30% solution B for 8 minutes,
40% solution A:60% solution B for 5 minutes, 10% solution A:90% solution
B for 2 minutes, 50% solution A:50% solution B for 2 minutes and 90%
solution A:10% solution B for 2 minutes over a time period of 32 minutes.
The capillary voltage was 1.5 kV, and a dry gas flow rate of 13 l/min was
used, with a temperature of 220 C˚. The scan range used was 100–3200 m/z.
The tandem mass spectra were annotated and peak list files (.MGF) were
generated. Data analysis was performed essentially as described previously
(Seo et al., 2008). Protein identification was performed by searching in the
National Center for Biotechnology Information non-redundant database
(NCBInR) using the Mascot program (Matrix Science) with the following
parameters: peptide mass tolerance, 1.2 Da; MS/MS ion tolerance, 0.6 Da;
taxonomy was limited to Mus musculus; allow up to one missed trypsin
cleavage site; variable modifications considered were: acetylation (K),
deamidation (N, Q), methylation (D, E), dimethylation (N, R, K), oxidation
(M, C), phosphorylation (S, T, Y), cysteine propionamide, conversion of
proline to pyroglutamic acid (pyro-Glu; P), pyro-Glu (N-terminal, E, Q),
nitrosylation (C), succinylation (K), ADP-ribosylation (K), palmitoylation
(C), myristoylation (N-terminal, G), farnesylation (C) and GPI anchor
(protein C-terminal). Only significant hits as defined by Mascot probability
analysis were considered. In addition, a minimum total score of 50,
comprising at least one peptide match of ion score.20 was arbitrarily set as
the threshold for acceptance (Seo et al., 2008).
In vitro interaction of GAPDH–apotransferrin by solid-
phase assays
In vitro interaction of GAPDH and apotransferrin was analyzed by ELISA
and surface plasmon resonance (SPR)-based affinity interaction analysis
by standard procedures as described previously (Raje et al., 2007). Briefly,
polystyrene ELISA plate wells were coated overnight at 4 C˚ using
150 nM/well of rabbit muscle GAPDH in PBS and blocked with 5%
bovine serum albumin (BSA) for 24 hours at 4 C˚. Wells were then
incubated with different concentrations of apotransferrin in PBST
(PBS+0.05% Tween-20) containing 0.5% BSA for 24 hours at 4 C˚.
After extensive washing, the bound apotransferrin was detected by
incubation with rabbit anti-transferrin antibody followed by goat anti-
rabbit-IgG–HRP. TMB H2O2 substrate for ELISA (Bangalore Genei) was
used to develop the reaction and the optical density (OD) was measured at
450 nm. As a positive control for apotransferrin, a set of wells were coated
with apotransferrin alone. Controls were also set up to determine the
nonspecific interaction of; (i) anti-transferrin antibody with GAPDH, (ii)
anti-transferrin antibody with BSA, (iii) transferrin with BSA, (iv)
secondary antibody with GAPDH and (v) secondary antibody with BSA.
Each set consisted of four wells in replicates. For the SPR assay,
biotinylated apotransferrin was immobilized on sensor chip SA (Biacore)
as per the manufacturer’s instructions (Biacore 3000). Subsequently,
increasing concentrations of GAPDH were used as an analyte in HBS-EP
buffer (Biacore) at pH 7.4. Regeneration of the sensor chip was performed
using 250 mM NaOH. Kon, Koff and KD values were determined by using
1:1 binding model Biacore 3000H evaluation software (Raje et al., 2007).
Apotransferrin binding to iron-loaded cells is pronase sensitive
and specific
Excess-iron-treated J774 cells were pretreated with 0.1% pronase
(Roche) or control buffer for 20 minutes at 4 C˚. Subsequently, cells
were washed with SFM and stained with apotransferrin–Alexa-Fluor-647
at 4 C˚ for 1 hour. Nonspecific binding was evaluated by incorporating
2006unlabeled apotransferrin in the staining mixture. All samples were
analyzed by flow cytometry.
Binding of apotransferrin to cells is saturable
The characteristics of apotransferrin binding to cells were assessed
essentially as described previously (Kumar et al., 2012). Briefly, J774
cells were cultured in 96-well plates (26104 cells/well) and loaded with
iron by incubation with 100 mM FeCl3 for 24 hours. Subsequently, cells
were incubated with increasing concentrations of biotinylated
apotransferrin, either alone or in the presence of 2006 unlabeled
apotransferrin (to evaluate nonspecific interactions) for 2 hours at 4 C˚.
This was followed by incubation with streptavidin–HRP (diluted 1:5000)
for 45 minutes at 4 C˚. The reaction was developed with TMB H2O2. To
determine the binding affinity, apotransferrin concentration versus OD
data was fitted by nonlinear regression for one site total saturable binding
using GraphPadH software.
Colocalization of cell surface proteins by confocal microscopy
Excess-iron-treated J774 cells were washed and blocked with neutral
buffer containing 5% each of FCS and normal human serum. For cell
surface colocalization of GAPDH and apotransferrin, cells were incubated
with 1 mg of monoclonal anti-GAPDH (Calbiochem), followed by rabbit
anti-mouse-IgG–Alexa-Fluor-568 (Molecular Probes) and 10 mg of
apotransferrin–FITC. For simultaneous colocalization of GAPDH,
apotransferrin and ferroportin, goat anti-ferroportin antibody (diluted
1:100; Santa Cruz Biotechnology) was included in the above antibody
incubation mixture. After extensive washing, cells were incubated with
rabbit anti-mouse-IgG–Alexa-Fluor-568 (for the detection of GAPDH),
followed by mouse anti-goat-IgG–FITC (Santa Cruz Biotechnology) and
10 mg of apotransferrin–Alexa-Fluor-647. All antibody incubations were
carried out sequentially at 4 C˚. Finally, cells were washed, fixed in 1%
paraformaldehyde and imaged with a confocal microscope (Nikon A1R),
using a 636oil-immersion objective and 1 Airy unit aperture as described
previously (Sheokand et al., 2013). The colocalization of signals was
visualized manually in the merged image, and Pearson’s correlation
coefficient was calculated using Nikon NIS-ElementsH software.
Interaction of GAPDH–apotransferrin and GAPDH–ferroportin
The interaction of proteins on the surface of iron-loaded J774
cells was assessed by confocal-microscopy-based colocalization, co-
immunoprecipitation and acceptor-photobleaching FRET analysis as
described previously (Raje et al., 2007; Sheokand et al., 2013). For co-
immunoprecipitation of GAPDH and apotransferrin, 26107 iron-treated
J774 cells were incubated with 500 mg of biotinylated apotransferrin in
1 ml of FACS buffer for 1 hour on ice. Controls were set up in parallel,
wherein the incubation of cells with biotinylated apotransferrin was
omitted. Cells were washed and processed for preparation of the
membrane protein fractions. Co-immunoprecipitation was performed
from these fractions using streptavidin–MagnabeadsH (Polysciences) as
per the manufacturer’s instructions. The beads were boiled in SDS
sample buffer, and eluted proteins were analyzed by western blotting
using a monoclonal anti-GAPDH antibody. For co-immunoprecipitation
of GAPDH and ferroportin, iron-treated J774 cells were processed for
preparation of the membrane protein fraction as described above. Co-
immunoprecipitation was performed using monoclonal anti-GAPDH
immobilized onto anti-mouse-IgG–MagnabeadsH (Polysciences). A
negative control was performed in parallel, wherein the membrane
fraction was co-immunoprecipitated using isotype control mouse IgG
immobilized on anti-mouse-IgG–Magnabeads. The beads were boiled in
SDS sample buffer, and eluted proteins were analyzed by western
blotting using an anti-ferroportin antibody.
In vivo study in a rodent model
Male Sprague-Dawley rats (150–170 g) of 4–6 weeks of age were
administered with a total of 700 mg of iron dextran intraperitoneally over
a 16-week period essentially as described previously (Brown et al.,
2007). These procedures were approved by the institutional animal ethics
committee. Groups of animals were sacrificed over a period of 1 week.
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Hepatocytes, peritoneal macrophages and enterocytes were isolated and
stained for surface GAPDH and apotransferrin, and analyzed by flow
cytometry. Liver tissue and serum samples were assayed for iron using
the Quantichrome iron assay kit.
Chromogenic iron-release assay
J774 cells were treated with 100 mM FeCl3 for 24 hours and harvested.
Aliquots of 16106 cells were incubated with 100 ml of SFM or SFM
supplemented with 0.3 mg apotransferrin at 37 C˚ for 1 hour.
Subsequently, cells were centrifuged (500 g, 5 minutes) to collect
supernatant. The cell pellet was washed three times with neutral buffer
(20 mM HEPES, 150 mM NaCl, 5 mM KCl and 1 mM each of CaCl2
and MgCl2). Both the cell pellet and the respective cell supernatant were
digested with 5% HNO3 at 80 C˚ for 2 hours to release iron. Samples were
concentrated in a Speed Vac concentrator, and iron estimation was
performed using a QuantichromeH iron assay kit (Bioassay systems) as
per the manufacturer’s instructions.
Iron-release assay using radioactive iron
Cells were loaded with iron either by incubation with FeCl3 or by
erythrophagocytosis (spleen macrophages, THP1 and J774) in complete
medium spiked with 500 nM of 55FeCl3 (ARC) at 37 C˚. Controls were
set up in parallel with complete medium containing 500 nM of 55FeCl3.
After 12 hours, cells were washed extensively with SFM and incubated
with 200 ml of SFM containing 2 mg/ml apotransferrin or with only SFM
(as a control). Subsequently, the cell-free supernatants were collected and
assayed for the presence of 55Fe by liquid scintillation counting.
Sequestration of exported iron by apotransferrin
J774 cells cultured in 24-well plates (36105 cells/well) were iron loaded
by FeCl3 treatment along with 500 nM
55FeCl3 as for the iron-release
assays described above. Cells were then incubated with 0.5 mg/ml
biotinylated apotransferrin at 37 C˚ for 1 hour in SFM. Subsequently, the
supernatant was collected and biotinylated apotransferrin was captured
using streptavidin–Magnabeads. Precipitated samples were blotted onto
nitrocellulose membrane and radioactive iron was detected using a
phosphoimager (Fujifilm FLA-9000).
Statistical analysis
All statistical analysis was performed using unpaired Student’s t-test.
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